Constellation Brands, Inc.
CorpDigest
Constellation Brands, Inc.
Company History
Founded 1945 in Rochester, New York
Last reviewed: 2025-07-15 · By Swet Parvadiya
Founded in 1945 as Canandaigua Industries by Marvin Sands in New York's Finger Lakes region, Constellation began as a bulk wine producer and spent six decades growing into a Fortune 500 beverage alcohol company. The original business was modest: buying bulk wine from other producers and selling it under the Canandaigua label. The company went public in 1973 and began acquiring wine brands systematically through the 1980s and 1990s.
Marvin Sands founded Constellation Brands' predecessor company, Canandaigua Industries, in 1945 in Canandaigua, New York. Starting with eight employees and $150,000 in first-year sales, Sands built the company into a regional wine powerhouse through value brands and strategic acquisitions. He took the company public in 1973 as Canandaigua Wine Company, providing capital for the acquisition spree that would define the company's growth strategy. Sands introduced Richard's Wild Irish Rose in 1954, which became a flagship brand. He served as chairman until his death in 1999. His sons, Richard and Robert Sands, succeeded him in leadership roles, with Richard becoming president in 1993 and CEO in 1996, and Robert later becoming CEO in 2007.
Marvin Sands establishes Canandaigua Industries in the Finger Lakes region of New York with eight employees, focusing on bulk wine production for East Coast bottlers. First-year sales total $150,000.
The company introduces Richard's Wild Irish Rose, a dessert wine that becomes its flagship brand and significantly expands market presence beyond bulk wine.
The company is incorporated as Canandaigua Wine Company, Inc., preparing for public market access.
Canandaigua Wine Company completes its IPO, providing capital for the acquisition-driven growth strategy that would define the company for decades.
The company purchases the Manischewitz winery in Canandaigua, New York, adding kosher wine capabilities and licensing the Manischewitz name.
Constellation acquires Barton Incorporated for $123 million, entering distilled spirits and imported beer distribution, including Corona Extra distribution rights. The deal doubles the company's size.
Canandaigua Brands Inc. is formed as the parent company of Canandaigua Wine Company and Barton Incorporated, reflecting the diversified portfolio.
The company acquires Napa Valley-based Franciscan Estates, one of the biggest California winery deals ever, establishing a powerful presence in premium and luxury wine markets.
Canandaigua Brands changes its name to Constellation Brands, signaling the company's breadth across wine, beer, and spirits categories.
Constellation acquires Robert Mondavi Corporation for approximately $1 billion, adding premium California wines and becoming the largest fine wine company in the United States.
Constellation and Grupo Modelo create the Crown Imports joint venture for U.S. beer imports, and the company acquires Spirits Marque One, bringing SVEDKA Vodka into the portfolio.
Constellation completes the $4.75 billion acquisition of Grupo Modelo's U.S. beer business from Anheuser-Busch InBev, gaining 100% ownership of Crown Imports, the Nava brewery, and exclusive perpetual U.S. rights to Corona and Modelo brands.
Constellation acquires Ballast Point Brewing for $1 billion, entering the craft beer segment.
Constellation acquires the Obregon brewery from Grupo Modelo for $600 million, achieving supply independence from the interim supply agreement.
Constellation invests $191 million in Canopy Growth, the Canadian cannabis company, beginning what would become a approximately $4 billion commitment.
Constellation invests an additional $3.8 billion in Canopy Growth, increasing its stake to 38% and making it the largest shareholder.
Constellation sells Ballast Point for a fraction of its $1 billion purchase price, and Bill Newlands succeeds Rob Sands as CEO in March 2019.
Constellation sells 30 low-cost wine brands to E. & J. Gallo for $810 million as part of its premiumization strategy.
Stockholders vote to eliminate Class B Convertible Common Stock and shift to a single class with one share, one vote rights. The Sands family receives $1.5 billion (pre-tax) for their enhanced voting shares.
Constellation relocates to a 170,000 square foot campus in Downtown Rochester, becoming the first Fortune 500 company to operate in the city in two decades.
Constellation completes the SVEDKA Vodka divestiture on January 6, 2025, and announces plans to divest remaining mainstream wine brands while retaining premium and luxury wines priced $15 and above.
Constellation acquired Grupo Modelo's U.S. beer business from Anheuser-Busch InBev as part of an antitrust settlement, gaining 100% ownership of Crown Imports, the Nava brewery in Mexico, and exclusive perpetual U.S. rights to Corona and Modelo brands.
Constellation acquired Robert Mondavi to add premium and super-premium California wines to its portfolio, accelerating the shift from value brands to higher-margin varietals.
Constellation acquired Barton to enter distilled spirits and imported beer distribution, including Corona Extra distribution rights.
Constellation acquired Ballast Point to enter the high-growth craft beer segment, which was expanding at double-digit rates at the time.
Constellation acquired the Obregon brewery from Grupo Modelo to achieve supply independence from the interim supply agreement and gain immediate functioning brewery capacity.
Constellation Brands was founded in 1945 by Marvin Sands as Canandaigua Industries in Canandaigua, New York, originally producing bulk wine for east coast distribution. The company grew systematically through acquisitions including Richards Wild Irish Rose (1969), Manischewitz wine (1986), and various other wine brands building national presence in fortified and table wines through 1970s-1990s. The transformational 2007 acquisition of Vincor International ($1.4B) added premium wine brands and Canadian distribution, while continued strategic moves built diversified alcoholic beverage portfolio. The 2013 Modelo beer acquisition from Anheuser-Busch InBev ($4.75 billion) represented the transformational deal — Constellation acquired exclusive US perpetual rights for Corona, Modelo Especial, Pacifico, and other Mexican beer brands creating dominant import beer position. Revenue grew from $50 million (1980) to $10.2 billion (FY2024) through patient strategic transformation toward premium alcoholic beverages.
Constellation Brands acquired exclusive perpetual US import rights for Corona, Modelo Especial, Pacifico, Negra Modelo, and Victoria from Anheuser-Busch InBev in June 2013 for $4.75 billion, with the transaction structured as US Justice Department-mandated divestiture to address antitrust concerns from AB InBev's acquisition of Grupo Modelo. The transformational acquisition gave Constellation Brands dominant US Hispanic beer category positioning plus Modelo Especial's eventual rise to #1 US beer brand by dollar sales in 2023, surpassing Bud Light during boycott controversy. Corona and Modelo brands generate approximately $9 billion in current annual Constellation revenue at premium margins (45%+ EBITDA margins for beer segment), transforming Constellation from wine-focused company into beer-dominated business. The acquisition represents one of consumer products industry's most successful transactions, with current beer business valuation approaching $50+ billion versus $4.75 billion acquisition cost demonstrating exceptional value creation.
Constellation Brands' $4 billion total investment in Canadian cannabis company Canopy Growth (2017-2018, building 38.6% ownership stake plus warrants supporting potential majority position) has resulted in multiple billions in write-downs as cannabis industry hasn't materialised as expected. The strategic bet anticipated US federal cannabis legalisation creating substantial market opportunity for major alcohol-cannabis crossover, though continued federal cannabis prohibition has prevented Constellation from realising US cannabis strategic positioning. Canopy Growth stock declined approximately 95% from 2018 peak, with Constellation taking $2.5+ billion in equity method losses through various periods plus additional fair value adjustments. The investment also included CBD-infused beverage development through Canopy supporting future market opportunity, though continued US regulatory uncertainty has prevented commercialisation. Strategic value remains uncertain pending potential US federal legalisation or various other regulatory developments. The Canopy investment represents Constellation's most controversial strategic decision generating sustained shareholder controversy.
Constellation Brands recorded approximately $1.2 billion in impairment charges related to wine and spirits business during FY2024-FY2025, reflecting continued declining sales in mainstream wine segment, premium wine competitive pressures, and various operational challenges including West Coast wildfire impacts on vineyard operations. The writedowns drove FY2024 net loss of $81 million despite operating segments generating substantial profitability, with continued strategic evaluation regarding wine and spirits portfolio creating potential additional restructuring activity. Strategic response includes continued portfolio rationalisation potentially including divestiture of mainstream wine brands while preserving premium wine positioning, accelerated focus on premium and luxury wine segments, and various other strategic adjustments. The wine business challenges contrast dramatically with continued beer business strength, creating strategic complexity managing two segments with very different dynamics. Future wine strategy depends on continued portfolio evaluation and potential strategic transactions affecting wine and spirits positioning.